Antai Weijing Completes Hundreds of Millions RMB Series B Financing to Advance Ultra-Micro, High-Precision Surgical Robotics

Recently, KouTech, a company specializing in ultra-micro and high-precision surgical robots, announced the completion of a multi-hundred million yuan Series B financing round. This round of financing was jointly participated by industrial capital and well-known investment institutions. The funds will mainly be used to consolidate the technological advantages of core products, improve the product ecosystem of microsurgical robots, accelerate the clinical registration process, and promote the international market layout.

Founded in 2022, KouTech is the world's first innovative enterprise focusing on a small, precision surgical robot platform. The company’s predecessor provided high-precision intelligent device R&D and production services to several internationally renowned medical device companies, accumulating over a decade of deep technical expertise in the field of precision medical device manufacturing. KouTech, in collaboration with its R&D centers in the United States and Japan, has independently developed the underlying components of surgical robots, servo systems, transmission mechanisms, and consumable components, breaking the bottleneck of reliance on imported key technologies. Additionally, the company has established in-depth cooperation with multiple universities and research institutions at home and abroad to jointly advance the development of engineering components and systems, forming a complete innovation chain from foundational technology to clinical application.